SUVA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 606,543 | 631,952 | 716,978 | 744,681 | 662,753 | 641,171 | 621,845 | 572,931 |
| Profit before tax | 209,682 | 227,546 | 309,995 | 288,401 | 259,200 | 236,218 | 251,479 | 226,942 |
| Net profit | 178,180 | 193,477 | 263,474 | 245,018 | 220,015 | 200,510 | 213,564 | 190,414 |
| Equity | 348,797 | 374,843 | 638,316 | 883,334 | 923,349 | 823,860 | 737,424 | 752,889 |
| Liabilities | 46,770 | 22,341 | 29,466 | 29,787 | 16,524 | 10,854 | 23,523 | 26,285 |
| Non-current assets | 10,735 | 28,138 | 21,389 | 31,919 | 24,107 | 17,917 | 11,412 | 8,356 |
| Current assets | 384,350 | 367,906 | 645,866 | 880,441 | 914,931 | 816,112 | 749,144 | 770,695 |
| Total assets | 395,085 | 396,044 | 667,255 | 912,360 | 939,038 | 834,029 | 760,556 | 779,051 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 193,645 | 184,371 | 165,658 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +0.6% | +4.2% | +13.5% | +3.9% | -11.0% | -3.3% | -3.0% | -7.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 45.1% | 48.9% | 39.5% | 26.9% | 23.4% | 24.0% | 28.1% | 24.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 51.1% | 51.6% | 41.3% | 27.7% | 23.8% | 24.3% | 29.0% | 25.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 29.4% | 30.6% | 36.7% | 32.9% | 33.2% | 31.3% | 34.3% | 33.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 34.6% | 36.0% | 43.2% | 38.7% | 39.1% | 36.8% | 40.4% | 39.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 303,272 | 315,976 | 358,489 | 372,341 | 331,377 | 320,586 | 310,923 | 286,466 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SUVA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-11-17 | 2022-11-18 | 263.04 |
SUVA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SUVA, UAB, a Private Limited Liability Company, is active in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €572.9K and net profit of €190.4K, with a profit margin of 33.2%. Revenue declined from €641.2K in 2023 to €621.8K in 2024 and then to €572.9K in 2025, showing a moderate downward trend over the three-year period. Net profit also eased from €200.5K in 2023 to €213.6K in 2024 and €190.4K in 2025, while profitability remained high. The balance sheet for 2025 shows total assets of €779.1K, equity of €752.9K and liabilities of €26.3K, indicating a very low leverage position. The equity ratio stood at 96.6%, with debt-to-equity of 0.03 and asset turnover of 0.74x. Return on equity was 25.3% and return on assets 24.4%. Revenue per employee was €286.5K, and profit per employee was €95.2K, reflecting solid operating productivity.